stockrowHims & Hers Health, Inc.
HIMS Healthcare Drug Manufacturers Specialty & Generic
Hims & Hers Health, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $2.3 billion, up 59.0% from fiscal 2024.
- Revenue
- +38.3%
- EPS
- −294.7%
- Free cash flow
- +5.09%
- Total debt
- +40.8%
Quarter to June 2026, against a year earlier
Follow HIMS
Alert me
Hims & Hers Health, Inc. (HIMS) Debt to equity
Hims & Hers Health, Inc.'s debt to equity at the end of the quarter to 30 June 2026 was 4.2×, up 2.4× from fiscal 2025 (1.8×). Over the past ten years it has ranged from 0.0× (fiscal 2024) to 1.8× (fiscal 2025) — the current reading is the highest in ten years. That is above the Drug Manufacturers Specialty & Generic industry median of 0.0× and above the Healthcare sector median of 0.0×.
Debt to equity, annual
Embed this chart
Annual newest first
| Period | Debt to equity | Change |
|---|---|---|
| FY2025 | 1.8× | — |
| FY2024 | 0.0× | — |
| FY2023 | 0.0× | — |
| FY2022 | 0.0× | — |
| FY2022 | 0.0× | — |
| FY2021 | 0.0× | — |
| FY2021 | 0.0× | — |
| FY2020 | 0.0× | — |
| FY2020 | 0.0× | — |
| FY2019 | 0.0× | — |
Quarterly newest first
| Period | Debt to equity | Change |
|---|---|---|
| Jun 2026 | 4.2× | 92.96% |
| Mar 2026 | 2.2× | 21.43% |
| Dec 2025 | 1.8× | 7.58% |
| Sep 2025 | 1.7× | (2.99%) |
| 25 more quarters | Free account |
Against its own ten years
Debt to equity against peers
| Company | Debt to equity |
|---|---|
| SUPN Indivior Pharmaceuticals Inc. compare | −8.1× |
| AMLX Amylyx Pharmaceuticals, Inc. compare | 0.0× |
| KNSA Kiniksa Pharmaceuticals International, plc compare | 0.0× |
| RDY Dr. Reddy's Laboratories Ltd compare | 0.2× |
| LNTH Lantheus Holdings, Inc. compare | 0.4× |
| ALKS Alkermes plc compare | 0.8× |
| LQDA Liquidia Corporation compare | 0.9× |
| HIMS Hims & Hers Health, Inc. | 4.2× |
| AMRX AMNEAL PHARMACEUTICALS, INC. compare | 6.0× |
| Drug Manufacturers Specialty & Generic industry median | 0.0× |
| Healthcare sector median | 0.0× |
| Market median | 0.1× |
What Debt to equity is
Debt to Equity Ratio shows how much a company relies on borrowed money compared with the money its shareholders have in the business.
(Long Term Debt (Total) + Current Part of Debt) ÷ Shareholders Equity (Total)
More on HIMS
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- The full statement